PMID- 34535199
OWN - NLM
STAT- MEDLINE
DCOM- 20210921
LR  - 20231102
IS  - 1008-8830 (Print)
IS  - 2096-9228 (Electronic)
IS  - 1008-8830 (Linking)
VI  - 23
IP  - 9
DP  - 2021 Sept 15
TI  - Shaanxi Provincial Diagnosis and Treatment Center of Kawasaki Disease.
PG  - 867-876
LID - 1008-8830(2021)09-0867-10 [pii]
LID - 10.7499/j.issn.1008-8830.2107110 [doi]
AB  - Kawasaki disease is an acute, self-limited vascuitis that mainly occurs in 
      children under 5 years of age. Intravenous immunoglobulin (IVIG) has become an 
      effective treatment regimen, which can effectively reduce the incidence of 
      cardiovascular complications. However, there has been no consensus or clinical 
      guidelines for the application of IVIG in children with Kawasaki disease till 
      now. This consensus is developed based on the current research progress on the 
      application of IVIG in children with Kawasaki disease in China and overseas, with 
      reference to the diagnosis and treatment guidelines for Kawasaki disease in China 
      and overseas, and the opinions of experts. This consensus provides 
      recommendations on the clinical application strategy of IVIG in children with 
      Kawasaki disease and the prevention and treatment of its adverse reactions. 
      Citation.
CN  - Shaanxi Provincial Diagnosis and Treatment Center of Kawasaki Disease
CN  - Clinical Research Center for Childhood Diseases of Shaanxi Province
CN  - Children's Hospital of Shaanxi Provincial People's Hospital
CN  - Editorial Board of Chinese Journal of Contemporary Pediatrics
CN  - Expert Committee of Advanced Training for Pediatrician, China Maternal 
      andChildren's Health Association
CN  - General Pediatrician Group, Society of Pediatrician, Chinese Doctor 
      Association(Du ZD,Email: duzhongdong@126.com)
LA  - eng
LA  - chi
PT  - Journal Article
TT  - 静脉输注免疫球蛋白在儿童川崎病中应用的专家共识.
PL  - China
TA  - Zhongguo Dang Dai Er Ke Za Zhi
JT  - Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
JID - 100909956
RN  - 0 (Immunoglobulins, Intravenous)
SB  - IM
MH  - Child
MH  - Child, Preschool
MH  - China
MH  - *Heart Diseases
MH  - Humans
MH  - Immunoglobulins, Intravenous/therapeutic use
MH  - *Mucocutaneous Lymph Node Syndrome/diagnosis/drug therapy
MH  - Treatment Outcome
PMC - PMC8480171
OAB - Kawasaki disease is an acute, self-limited vascuitis that mainly occurs in 
      children under 5 years of age. Intravenous immunoglobulin (IVIG) has become an 
      effective treatment regimen, which can effectively reduce the incidence of 
      cardiovascular complications. However, there has been no consensus or clinical 
      guidelines for the application of IVIG in children with Kawasaki disease till 
      now. This consensus is developed based on the current research progress on the 
      application of IVIG in children with Kawasaki disease in China and overseas, with 
      reference to the diagnosis and treatment guidelines for Kawasaki disease in China 
      and overseas, and the opinions of experts. This consensus provides 
      recommendations on the clinical application strategy of IVIG in children with 
      Kawasaki disease and the prevention and treatment of its adverse reactions. 
      Citation:
OABL- eng
OTO - NOTNLM
OT  - Child
OT  - Expert consensus
OT  - Intravenous immunoglobulin
OT  - Kawasaki disease
OT  - Self-limited vasculitis
COIS- 共识由小组内成员自行完成，未接受赞助，小组内成员不存在任何利益冲突。
EDAT- 2021/09/19 06:00
MHDA- 2021/09/22 06:00
PMCR- 2021/09/15
CRDT- 2021/09/18 05:29
PHST- 2021/09/18 05:29 [entrez]
PHST- 2021/09/19 06:00 [pubmed]
PHST- 2021/09/22 06:00 [medline]
PHST- 2021/09/15 00:00 [pmc-release]
AID - 1008-8830(2021)09-0867-10 [pii]
AID - 10.7499/j.issn.1008-8830.2107110 [doi]
PST - ppublish
SO  - Zhongguo Dang Dai Er Ke Za Zhi. 2021 Sept 15;23(9):867-876. doi: 
      10.7499/j.issn.1008-8830.2107110.